The Asia-Pacific cardiac arrhythmia monitoring devices market is expected to register a high CAGR during the forecast period of 2018–2023. Cardiac arrhythmia monitoring devices are extremely useful in tracking the heart function and report any abnormalities in normal function (rhythm). Hence, they do not just help in maintaining a continuous record of heart function but have also proven to be lifesavers due to their ability to report abnormalities in normal heart function, like in the case of a cardiac event.
Increasing Use of Telecardiology
In disorders like cardiac arrhythmia, cardiac monitoring is not just essential but is needed continuously. Cardiac arrhythmia is not fully curable, and it is not practical to retain a patient in the hospital for extremely long durations or to ask a patient to visit the hospital every day (that too for several times a day in some cases). The best possible way to continuously monitor the patients suffering from cardiac arrhythmia is through remote patient monitoring by using cardiac arrhythmia monitoring devices. This, in technical terms, is referred to as telecardiology. In telecardiology, the patients suffering from cardiac arrhythmia are given a cardiac arrhythmia monitoring device which is then fixed superficially on the chest area of the patient. These devices monitor heart rhythm through a set of two or three electrodes and record any abnormalities in heart function, and some of these devices can even autonomously record an abnormality or a cardiac event and alert the healthcare professionals. Most of these devices can be monitored remotely, making it possible to effectively and efficiently monitor the patients suffering from cardiac arrhythmia. As it is extremely convenient to monitor the patients remotely, as compared to regular patient visits to hospitals, telecardiology is becoming extremely popular both among the patients and doctors. This growth in telecardiology means the increase in demand for cardiac arrhythmia monitoring devices, which will ultimately drive the market for these devices. The other factors, such as ease of use, portability of cardiac arrhythmia monitoring devices, and development of smart cardiac monitors are driving the Asia-Pacific cardiac arrhythmia monitoring devices market.
Quality Cannot be Controlled by the Devices
Most of the cardiac arrhythmia monitoring devices come with an automatic analysis software, which analyses the signal. But this analysis depends entirely on signal quality, which in turn is dependent on several different factors, such as proper attachment of the electrodes to the patient’s body, electromagnetic disturbance due to other devices in the vicinity, like smartphones, and other factors, such as muscle tremors. These devices cannot control these factors and often result in a bad quality signal, which results in the wrong analysis by the analysis software. Often, this wrong analysis is considered by patients as the defect in the device itself and this is leading to a loss of faith in these devices. This is ultimately affecting the sales of these devices and is hindering the market. The other factors, such as poor adoption of telemetry technology in Asia-Pacific markets and the high cost of remote cardiac arrhythmia monitoring are also hindering the growth of the Asia-Pacific cardiac arrhythmia monitoring devices market.
China Leads the Market
In 2017, the Chinese cardiac arrhythmia monitoring devices market held the largest market share in Asia-Pacific due to the presence of quality healthcare system and a huge population with high rate of cardiac diseases in this region.
Key Developments in the Market
- December 2017: Philips acquired Vital Health.
- July 2017: BioTelemetry (BEAT) acquired LifeWatch.
The major players include GE Healthcare, Medtronic's, Philips Healthcare, Cardiac Science Corp., and BioTelemetry, among others.
Reasons to Purchase the Report
- Follow the current and future Asia-Pacific cardiac arrhythmia monitoring devices market in the developed and emerging markets.
- Examine the various perspectives of the market with the help of Porter’s Five Forces Analysis.
- Identify the segment that is expected to dominate the market.
- Identify the regions that are expected to witness the fastest growth during the forecast period.
- Identify the latest developments, market shares, and strategies employed by the major market players.
- 3-month analyst support along with the Market Estimate sheet (in Excel).
Customization of the Report
- This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Products and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1.1 Increasing Use of Telecardiology
6.1.2 Ease of Use and Portability of Cardiac Arrhythmia Monitoring Devices
6.1.3 Development of Smart Cardiac Monitors
6.2.1 Quality Cannot be Controlled by the Devices
6.2.2 Poor Adoption of Telemetry Technology in the Asia-Pacific Market
6.2.3 High Cost of Remote Cardiac Arrhythmia Monitoring
6.4 Key Challenges
7. Market Segmentation
7.1 By Devices
7.1.1 Cardiac Telemetry Devices
7.1.2 Event Monitoring Devices
7.1.3 Continuous Rhythm Monitoring Devices
7.1.4 Holter Monitoring Devices
7.2 By Service Providers
7.2.1 Mobile Cardiac Telemetry Monitoring Service Providers
7.2.2 Independent Diagnostic Testing Facilities/Clinics
7.3 By Geography
188.8.131.52 Australia & New Zealand
184.108.40.206 South Korea
220.127.116.11 Rest of Asia-Pacific
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Biotelemetry, Inc.
9.2 Cardiac Science Corp.
9.3 GE Healthcare
9.5 Philips Healthcare
*List not Exhaustive
10. Future of the Market